Clearlake Capital Backed nThrive To Acquire TransUnion's Healthcare Business

Go back to Clearlake Capital Backed nThrive To Acquire TransUnion's Healthcare Business

TransUnion (TRU) PT Raised to $143 at Goldman Sachs

October 26, 2021 4:16 PM EDT

Goldman Sachs analyst George K. Tong raised the price target on TransUnion (NYSE: TRU) to $143.00 (from $140.00) while maintaining a Buy rating.

... More